Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 17751 - 17775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	ALG2	85365	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ALG2 mRNA	9q22.33	A21749
Copper	Approved Investigational	ALKBH4	54784	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ALKBH4 mRNA	7q22.1	A21749
Copper	Approved Investigational	ALPK1	80216	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ALPK1 mRNA	4q25	A21749
Copper	Approved Investigational	ALS2	57679	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ALS2 mRNA	2q33.1	A21749
Copper	Approved Investigational	AMOTL2	51421	upregulated	[NSC 689534 binds to Copper] which results in increased expression of AMOTL2 mRNA	3q22.2	A21749
Copper	Approved Investigational	ANAPC1	64682	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ANAPC1 mRNA	2q13	A21749
Copper	Approved Investigational	ANGPT2	285	downregulated	Copper results in decreased expression of ANGPT2 mRNA	8p23.1	A21752
Copper	Approved Investigational	ANGPTL4	51129	downregulated	[Disulfiram binds to Copper] which results in decreased expression of ANGPTL4 mRNA	19p13.2	A21750
Copper	Approved Investigational	ANGPTL4	51129	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ANGPTL4 mRNA	19p13.2	A21749
Copper	Approved Investigational	ANKH	56172	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ANKH mRNA	5p15.2	A21749
Copper	Approved Investigational	ANKRD12	23253	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ANKRD12 mRNA	18p11.22	A21749
Copper	Approved Investigational	ANKRD37	353322	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ANKRD37 mRNA	4q35.1	A21749
Copper	Approved Investigational	ANKS6	203286	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ANKS6 mRNA	9q22.33	A21749
Copper	Approved Investigational	ANLN	54443	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ANLN mRNA	7p14.2	A21749
Copper	Approved Investigational	ANO10	55129	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ANO10 mRNA	3p22.1-p21.33	A21749
Copper	Approved Investigational	ANO6	196527	upregulated	[Disulfiram binds to Copper] which results in increased expression of ANO6 mRNA	12q12	A21750
Copper	Approved Investigational	ANP32A	8125	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ANP32A mRNA	15q23	A21749
Copper	Approved Investigational	ANXA3	306	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ANXA3 mRNA	4q21.21	A21749
Copper	Approved Investigational	AOC2	314	upregulated	[NSC 689534 binds to Copper] which results in increased expression of AOC2 mRNA	17q21.31	A21749
Copper	Approved Investigational	AOC3	8639	upregulated	[NSC 689534 binds to Copper] which results in increased expression of AOC3 mRNA	17q21.31	A21749
Copper	Approved Investigational	AOX1	316	upregulated	[NSC 689534 binds to Copper] which results in increased expression of AOX1 mRNA	2q33.1	A21749
Copper	Approved Investigational	AP3M1	26985	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of AP3M1 mRNA	10q22.2	A21749
Copper	Approved Investigational	AP5Z1	9907	upregulated	[NSC 689534 binds to Copper] which results in increased expression of AP5Z1 mRNA	7p22.1	A21749
Copper	Approved Investigational	APBA2	321	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of APBA2 mRNA	15q13.1	A21749
Copper	Approved Investigational	APBB3	10307	upregulated	[Disulfiram binds to Copper] which results in increased expression of APBB3 mRNA	5q31.3	A21750

Displaying entries 17751 - 17775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability